Selective Serotonin Reuptake Inhibitors

53Citations
Citations of this article
228Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The first antidepressants were created by chance but brought the idea that central serotonin agonism produced an antidepressant effect. SSRIs were the first class of psychotropic medications to be rationally designed, meaning that researchers intended to utilize a specific mechanism of action while avoiding adverse effects. In this way, SSRIs were created to be safer and more tolerable than previous antidepressants. SSRIs share many similarities, but differ in terms of pharmacokinetics and effects on CYP450 enzymes, which is detailed in this chapter. Further information will be provided regarding safety, clinical indications/uses, and dosing recommendations.

Cite

CITATION STYLE

APA

Lochmann, D., & Richardson, T. (2019). Selective Serotonin Reuptake Inhibitors. In Handbook of Experimental Pharmacology (Vol. 250, pp. 135–144). Springer New York LLC. https://doi.org/10.1007/164_2018_172

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free